Raymond H Diradoorian
CIK 1352121 · EVPGlobal Technical Operations · last filed 2024-07-10
Raymond H Diradoorian is an EVPGlobal Technical Operations who has filed 39 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for LFCR, was dated Jul 10, 2024. Across all open-market trades the lifetime net is −$17.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $445.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2811 AIRPARK DRIVE
SANTA MARIA, CA 93455
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LFCR | Director | 69,978 | $6.37 | $445.8K | $0 | 6 | 2024-07-10 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | — | $8.76 | — | $0 | 2 | 2022-06-02 |
| ALLERGAN INC (AGN) Delisted | EVPGlobal Technical Operations | 11,346 | — | — | -$17.73M | 30 | 2015-02-24 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-10 | LFCR | Grant (A) | +30,000 | $0 | EDGAR |
| 2024-02-02 | LFCR | Exer (M) | +9,554 | $0 | EDGAR |
| 2023-06-05 | LFCR | Grant (A) | +18,182 | $0 | EDGAR |
| 2023-06-01 | LFCR | Exer (M) | +9,474 | $0 | EDGAR |
| 2023-02-02 | LFCR | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | LFCR | Mixed | +2,768 | $19.4K | EDGAR |
| 2022-06-02 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-24 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | — | Mixed | −18,098 | $0 | |
| 2015-02-24 | ALLERGAN INC (AGN) Delisted | Mixed | +172 | -$24.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.